By the end of 2024, Bangladesh had registered 12,422 cumulative HIV cases, of which 2,281 had died. Health experts estimate that around 16,863 people are currently living with HIV in the country.
For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...
The Punch on MSN
Reimagining HIV financing for Africa
Dr David Adetula is the Founder of Healthialogue and Convener of the Healthialogue Panel Session and Discussion Forum and Christian Okike is the President of the Medical Research and Humanitarian ...
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...
In April 2025, we published a story with the headline: "Haunted by hopelessness: 12 Zambians share their stories as HIV drugs run out." It looked at the impact of President Trump's cuts to foreign aid ...
WASHINGTON (AP) — The U.S. is purchasing enough doses of a new twice-a-year HIV prevention shot to share with up to 2 million people in poor countries by 2028, the State Department announced Thursday.
The U.S. announced Thursday that it will make an investment in the new HIV prevention drug called lenacapavir that's been hailed as a "breakthrough" and a "game changer" by the medical community. The ...
Sept. 4 (UPI) --Health officials on Thursday said they are optimistic about a relatively new HIV antiviral medication called lenacapavir that they hope will reach 2 million people by 2028. Members of ...
The plan to target pregnant and breastfeeding mothers will be administered through the President’s Emergency Plan for AIDS Relief. Critics said it appeared to sidestep LGBTQ+ people. The Trump ...
Hosted on MSN
HIV: Monthly PrEP drug candidate shows promise
A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...
A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, USA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results